Intellectia LogoIntellectia
Product
Resources
Markets
News
Partner Program
Pricing
Log inTry for Free
Intellectia Logo
Log in
Intellectia Logo

Product

Features
Financial AI Agent
Stock Technical Analysis
Stock Monitor
Hedge Fund Tracker
AI Screener
Trading Strategies
AI Stock Picker
Swing Trading
Quant AI
Stock Chart Patterns
Daytrading Center
AI Earnings Prediction
Whales Auto Tracker
Backtesting Playground

Resources

Learn
Blog
Earnings
Tutorial
Help Center
Company
About Us
Contact
Press
Reward Program
Partner Program
Tools
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Compare
TradingView
SeekingAlpha

Markets

Trending Stocks
Hot Crypto
Trending News
All Stocks

News

Trading News
Overview
Top News
Daily Market Brief
Earnings
Latest
Newswire
Stock News
Crypto News
Monitor News
Partner ProgramPricing
Start for Free
  1. Home
    2. >
  2. Stock
    3. >
  3. INGN
stocks logo

INGN

-
collectAdd to Watchlistadvanced chartAdvanced Chart
$
0.000
0(0.000%)1D
collectadvanced chart
    Overview
    Forecast
    Valuation
    Earnings
High
--
Open
--
VWAP
--
Vol
--
Mkt Cap
--
Low
--
Amount
--
EV/EBITDA(TTM)
--
Total Shares
--
EV
--
EV/OCF(TTM)
--
P/S(TTM)
--
AI Stock Picker
AI Stock Picker

Market Estimates

Earnings Estimates
Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2025Q4
FY2026Q1
FY2026Q2
88.60M
+10.64%
-0.330
-19.51%
90.80M
+10.35%
-0.220
-12%
100.20M
+8.59%
-0.145
-3.33%
Estimates Revision
The market is revising Downward the revenue expectations for Inogen, Inc. (INGN) for FY2025, with the revenue forecasts being adjusted by -0.1% over the past three months. During the same period, the stock price has changed by -13.81%.
Revenue Estimates for FY2025
Revise Downward
down Image
-0.1%
In Past 3 Month
EPS Estimates for FY2025
Revise Downward
down Image
-4.15%
In Past 3 Month
Stock Price
Go Down
down Image
-13.81%
In Past 3 Month
Wall Street analysts forecast INGN stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for INGN is 13.00 USD with a low forecast of 12.00 USD and a high forecast of 14.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
2 Analyst Rating
Wall Street analysts forecast INGN stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for INGN is 13.00 USD with a low forecast of 12.00 USD and a high forecast of 14.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
2 Buy
0 Hold
0 Sell
Moderate Buy
Current: 6.990
sliders
Low
12.00
Averages
13.00
High
14.00
Current: 6.990
sliders
Low
12.00
Averages
13.00
High
14.00
B. Riley
NULL -> Buy
initiated
$14
2025-06-17
Reason
B. Riley
Price Target
$14
2025-06-17
initiated
NULL -> Buy
Reason
B. Riley initiated coverage of Inogen with a Buy rating and $14 price target.
B. Riley
Anderson Schock
Buy
initiated
$14
2025-06-17
Reason
B. Riley
Anderson Schock
Price Target
$14
2025-06-17
initiated
Buy
Reason
Needham
Hold
to
Buy
upgrade
$12
2025-05-22
Reason
Needham
Price Target
$12
2025-05-22
upgrade
Hold
to
Buy
Reason
Needham
Mike Matson
Hold
Reiterates
n/a
2025-04-09
Reason
Needham
Mike Matson
Price Target
n/a
2025-04-09
Reiterates
Hold
Reason
Needham
Mike Matson
Hold
Reiterates
n/a
2025-02-27
Reason
Needham
Mike Matson
Price Target
n/a
2025-02-27
Reiterates
Hold
Reason
Needham
Mike Matson
Hold
Reiterates
n/a
2025-02-26
Reason
Needham
Mike Matson
Price Target
n/a
2025-02-26
Reiterates
Hold
Reason
See All Ratings

Valuation Metrics

The current forward P/E ratio for Inogen Inc (INGN.O) is -8.47, compared to its 5-year average forward P/E of -830.19. For a more detailed relative valuation and DCF analysis to assess Inogen Inc 's fair value, click here.
  • Forward PE
  • Forward EV/EBITDA
  • Forward PS

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PE
-830.19
Current PE
-8.47
Overvalued PE
2743.64
Undervalued PE
-4404.01

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average EV/EBITDA
19.45
Current EV/EBITDA
0.00
Overvalued EV/EBITDA
160.09
Undervalued EV/EBITDA
-121.19

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PS
1.41
Current PS
0.00
Overvalued PS
2.56
Undervalued PS
0.26
Financial AI Agent
Financial AI Agent

Financials

Annual
Quarterly
N/A
Total Revenue
N/A
Operating Profit
N/A
Net Income after Tax
N/A
EPS - Diluted
N/A
Free Cash Flow
N/A
Gross Profit Margin - %
N/A
Net Margin - %

Trading Trends

  • Insider
  • Hedge Fund
  • Congress Trading
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
Bought
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Intellectia AI SwingMax
Intellectia AI SwingMax

INGN News & Events

Events Timeline

(ET)
2025-09-25
16:08:10
Inogen appoints Naga Rameswamy as Chief Technology Officer
select
2025-08-07 (ET)
2025-08-07
17:03:35
Inogen reports Q2 EPS (15c), one estimate (9c)
select
2025-05-07 (ET)
2025-05-07
17:23:41
Inogen reports Q1 EPS (25c) vs. (62c) last year
select
Sign Up For More Events
Sign Up For More Events

News

[object Object]
Preview
4.0
09-09NASDAQ.COM
Wall Street Analysts Predict 35.64% Growth Potential for Inogen (INGN): Is Such a Surge Possible?

  • Stock Performance and Price Targets: Inogen (INGN) shares have risen 25.2% recently, with Wall Street analysts suggesting a mean price target of $11, indicating a potential upside of 35.6%, despite some estimates predicting declines.

  • Analyst Insights and Earnings Revisions: Analysts show growing optimism for INGN's earnings, with a Zacks Rank #2 (Buy) reflecting strong agreement on positive earnings revisions, which historically correlate with stock price movements.

[object Object]
Preview
9.5
08-10Yahoo Finance
Inogen Second Quarter 2025 Earnings: Beats Expectations

  • Inogen's Financial Performance: Inogen reported a revenue of US$92.3 million for 2Q 2024, a 4% increase from the previous quarter, with a net loss of US$4.15 million, which is a 26% improvement from the prior period. The company's earnings per share also improved significantly, surpassing analyst expectations.

  • Industry Outlook and Stock Movement: Revenue growth is projected at 6.2% annually over the next three years, while the Medical Equipment industry in the US is expected to grow by 8.2%. Additionally, Inogen's shares have increased by 4.3% over the past week, despite one identified warning sign regarding the company.

[object Object]
Preview
9.5
08-08NASDAQ.COM
Inogen Stock Gains Following Q2 Earnings Beat, Revenues Up Y/Y

  • Financial Performance: Inogen, Inc. reported an adjusted loss per share of 2 cents for Q2 2025, an improvement from a 7-cent loss in the previous year, with revenues of $92.3 million, up 4% year-over-year, surpassing estimates.

  • Market Outlook and Developments: The company introduced new products aimed at enhancing patient care while facing challenges such as declining direct-to-consumer sales and rental revenues; it expects revenue growth of approximately 6% for 2025.

Sign Up For More News

People Also Watch

FAQ

arrow icon

What is Inogen Inc (INGN) stock price today?

The current price of INGN is 6.99 USD — it has increased 1.16 % in the last trading day.

arrow icon

What is Inogen Inc (INGN)'s business?

Inogen, Inc. is a medical technology company offering respiratory products for use in the homecare setting. It supports patient respiratory care by developing, manufacturing, and marketing portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. Its Inogen One and Inogen Rove systems concentrate the air around the patient to offer a source of supplemental oxygen with a battery and can be plugged into an outlet when at home, in a car, or in a public place with outlets available. Its Inogen One and Inogen Rove systems reduce the patient’s reliance on stationary concentrators and scheduled deliveries of tanks with a finite supply of oxygen. Inogen Connect is a wireless connectivity platform for the Inogen One G4, Inogen One G5, Inogen Rove 4, and Inogen Rove 6, consisting of a front-end mobile application for use by long-term oxygen therapy users. It offers Simeox, which is an airway clearance device.

arrow icon

What is the price predicton of INGN Stock?

Wall Street analysts forecast INGN stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for INGN is 13.00 USD with a low forecast of 12.00 USD and a high forecast of 14.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

arrow icon

What is Inogen Inc (INGN)'s revenue for the last quarter?

Inogen Inc revenue for the last quarter amounts to 92.39M USD, increased 4.00 % YoY.

arrow icon

What is Inogen Inc (INGN)'s earnings per share (EPS) for the last quarter?

Inogen Inc. EPS for the last quarter amounts to -0.20 USD, decreased -20.00 % YoY.

arrow icon

What changes have occurred in the market's expectations for Inogen Inc (INGN)'s fundamentals?

The market is revising Downward the revenue expectations for Inogen, Inc. (INGN) for FY2025, with the revenue forecasts being adjusted by -0.1% over the past three months. During the same period, the stock price has changed by -13.81%.
arrow icon

How many employees does Inogen Inc (INGN). have?

Inogen Inc (INGN) has 766 emplpoyees as of December 05 2025.

arrow icon

What is Inogen Inc (INGN) market cap?

Today INGN has the market capitalization of 189.77M USD.

Intellectia LogoIntellectiaIntellectia LogoIntellectia

Redefine Your Investment Decisions

TwitterTwitterYoutubeYoutubeQuoraQuoraDiscordDiscordLinkedinLinkedinTelegramTelegram
AppStoreGooglePlay

Copyright © 2025 Intellectia.AI. All Rights Reserved.

pci certified logo
Company
HomeContactAbout UsNews Release
Compare
TradingViewSeeking Alpha
Features
Financial AI AgentStock Technical AnalysisStock MonitorHedge Fund TrackerAI ScreenerDaytrading Center
Strategies
AI Stock PickerSwing TradingStock Chart PatternsEarnings TradingDaytrading CenterAI Earnings PredictionQuant AIWhales Auto TrackerBacktesting Playground
Free Tools
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Resource
BlogTutorialEarningsTrending StocksCrypto MarketPartner ProgramTerms of UsePrivacy PolicySecuritySitemap
Start for Free